X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1277) 1277
oncology (1129) 1129
female (741) 741
middle aged (620) 620
chemotherapy (607) 607
antineoplastic combined chemotherapy protocols - therapeutic use (552) 552
male (547) 547
aged (543) 543
adult (538) 538
high-dose leucovorin (518) 518
fluorouracil - administration & dosage (425) 425
cancer (411) 411
5-fluorouracil (392) 392
fluorouracil (361) 361
index medicus (346) 346
treatment outcome (344) 344
high-dose chemotherapy (270) 270
leucovorin - administration & dosage (269) 269
antineoplastic combined chemotherapy protocols - adverse effects (261) 261
carcinoma (255) 255
folinic acid (254) 254
colorectal neoplasms - drug therapy (236) 236
pharmacology & pharmacy (210) 210
phase-ii trial (197) 197
randomized trial (196) 196
colorectal cancer (184) 184
antineoplastic agents - therapeutic use (182) 182
cisplatin (180) 180
combined modality therapy (166) 166
survival analysis (165) 165
fluorouracil - adverse effects (164) 164
survival rate (163) 163
care and treatment (162) 162
neoplasm staging (162) 162
drug administration schedule (160) 160
medicine & public health (158) 158
oxaliplatin (156) 156
phase-ii (153) 153
colorectal neoplasms - pathology (149) 149
radiotherapy (148) 148
breast neoplasms - drug therapy (144) 144
randomized-trial (144) 144
surgery (144) 144
animals (143) 143
leucovorin (142) 142
aged, 80 and over (141) 141
antineoplastic combined chemotherapy protocols - administration & dosage (141) 141
high-dose methotrexate (138) 138
antineoplastic agents - adverse effects (135) 135
adenocarcinoma - drug therapy (134) 134
therapy (134) 134
continuous-infusion (132) 132
infusions, intravenous (132) 132
fluorouracil - therapeutic use (131) 131
cisplatin - administration & dosage (129) 129
irinotecan (127) 127
high-dose 5-fluorouracil (125) 125
chemotherapy, adjuvant (124) 124
breast cancer (123) 123
disease-free survival (123) 123
hematology (121) 121
neoplasms - drug therapy (120) 120
prognosis (119) 119
trial (116) 116
neoplasm metastasis (111) 111
organoplatinum compounds - administration & dosage (111) 111
doxorubicin (105) 105
1st-line treatment (104) 104
camptothecin - analogs & derivatives (103) 103
stomach neoplasms - drug therapy (103) 103
research (102) 102
methotrexate (95) 95
survival (95) 95
dose-response relationship, drug (93) 93
phase-iii trial (92) 92
clinical trials as topic (91) 91
combination chemotherapy (91) 91
retrospective studies (91) 91
antimetabolites, antineoplastic - administration & dosage (90) 90
follow-up studies (89) 89
biochemical modulation (87) 87
colony-stimulating factor (86) 86
health aspects (85) 85
hematology, oncology and palliative medicine (85) 85
antineoplastic agents - administration & dosage (82) 82
breast neoplasms - pathology (82) 82
liver neoplasms - secondary (82) 82
prospective studies (81) 81
adjuvant chemotherapy (80) 80
combination (80) 80
deoxycytidine - analogs & derivatives (80) 80
antimetabolites, antineoplastic - therapeutic use (79) 79
leucovorin - adverse effects (79) 79
camptothecin - administration & dosage (78) 78
radiation-therapy (78) 78
radiology, nuclear medicine & medical imaging (78) 78
toxicity (78) 78
squamous-cell carcinoma (77) 77
metastasis (74) 74
risk factors (74) 74
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1537) 1537
German (21) 21
French (14) 14
Italian (4) 4
Chinese (2) 2
Polish (1) 1
Spanish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


European Journal of Cancer, ISSN 0959-8049, 2008, Volume 44, Issue 15, pp. 2204 - 2211
Journal Article
Annals of Oncology, ISSN 0923-7534, 08/2003, Volume 14, Issue 8, pp. 1258 - 1263
Journal Article
Journal Article
Expert Opinion on Orphan Drugs, ISSN 2167-8707, 03/2019, Volume 7, Issue 3, pp. 95 - 103
Introduction: In 2015, vistogard was approved both the US FDA and the European Medicines Agency (EMA) as an antidote in the treatment of 5-FU poisoning... 
uridine | capecitabine | 5-Fluorouracil | vistogard | fluoropyrimidines | PN401 | DPYD gene | LEUCOVORIN | PHASE-II | CARDIOTOXICITY | TOXICITY | ANTITUMOR-ACTIVITY | HIGH-DOSE 5-FLUOROURACIL | RESCUE | COLORECTAL-CANCER | PHARMACOLOGY & PHARMACY | 5-FU
Journal Article
American Journal of Clinical Oncology: Cancer Clinical Trials, ISSN 0277-3732, 2002, Volume 25, Issue 1, pp. 23 - 30
Journal Article
International Journal of Cancer, ISSN 0020-7136, 02/2011, Volume 128, Issue 3, pp. 682 - 690
Journal Article
Nature Medicine, ISSN 1078-8956, 08/2000, Volume 6, Issue 8, pp. 879 - 885
Journal Article
Psychopharmacology, ISSN 0033-3158, 9/2008, Volume 199, Issue 4, pp. 527 - 538
Journal Article
European Journal of Cancer, ISSN 0959-8049, 2013, Volume 49, Issue 8, pp. 1868 - 1875
Journal Article